March 23, 2017
March 23, 2017 —
In a new paper, researchers at University of California San Diego School of Medicine, along with colleagues in Brazil and Spain, describe the phenotypic spectrum or set of observable characteristics of congenital Zika (ZIKV) syndrome, based upon clinical evaluations and neuroimaging of 83 Brazilian children with presumed or confirmed ZIKV congenital infections.
March 21, 2017
March 21, 2017 —
In a new study, researchers at the University of California San Diego School of Medicine, University of Cyprus and Stanford University map the complex biological cascade caused by MIA: the expression of multiple genes involved in autism are turned up or down by MIA, affecting key aspects of prenatal brain development that may increase risk for atypical development later in life.
March 21, 2017
March 21, 2017 —
An international team of scientists, led by researchers at University of California San Diego School of Medicine and University of California San Francisco, has developed a novel genetic score that allows individuals to calculate their age-specific risk of developing Alzheimer’s disease (AD), based upon genetic information.
March 21, 2017
March 21, 2017 —
Standard antidepressant medications don’t work for everyone, and even when they do they are slow to kick in. In an effort to find better depression treatments, researchers at University of California San Diego School of Medicine discovered that inhibiting an enzyme called Glyoxalase 1 (GLO1) relieves signs of depression in mice. Moreover, inhibiting GLO1 worked much faster than the conventional antidepressant Prozac.
March 20, 2017
March 20, 2017 —
Genetic mutations that cause cancer also weaken cancer cells, allowing researchers to develop drugs that will selectively kill them. This is called “synthetic lethality” because the drug is only lethal to mutated (synthetic) cells. Researchers at UC San Diego School of Medicine and Jacobs School of Engineering developed a method to search for synthetic-lethal gene combinations. The technique, published March 20 in Nature Methods, uncovered 120 new opportunities for cancer drug development.
March 20, 2017
March 20, 2017 —
Kyoto University of Japan, one of the University of California San Diego’s international partners, will open an office in San Diego in early April, both campuses have announced.
March 14, 2017
March 14, 2017 —
An international research team, led by scientists at University of California San Diego School of Medicine, has created the first cellular model of anorexia nervosa (AN), reprogramming induced pluripotent stem cells (iPSCs) derived from adolescent females with the eating disorder.
March 13, 2017
March 13, 2017 —
Each year, at precisely the same moment — 12 p.m. on the East coast, 9 a.m. on the West — thousands of graduating medical school students across the country simultaneously tear open an envelope. The single sheet of paper inside informs each graduate where he or she will do their residencies — in other words, where each will spend the first several years of their careers as working doctors.
March 8, 2017
March 8, 2017 —
Patients with drug-refractory epilepsy have a new treatment option at UC San Diego Health. Instead of traditional surgery, patients may be eligible for a novel technique that allows surgeons to target the abnormal area of brain with laser technology. The MRI-guided laser ablation treatment is a new first-line therapy for patients diagnosed with epilepsy.
March 3, 2017
March 3, 2017 —
UC San Diego Research Affairs –The Office of Innovation and Commercialization launches the first of an eighteen-month entrepreneurial seminar series, free and open to anyone at UC San Diego and the general public, including members of any other research institutions, Mar. 9.
